Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction

by David M. Kaye, Shane Nanayakkara
Published 2019-09-01

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy

by Po-Yin Chu, Mandar S. Joshi, Duncan Horlock, Helen Kiriazis, David M. Kaye, David M. Kaye
Published 2019-02-01

Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction

by Shane Nanayakkara, Hitesh C Patel, David M Kaye
Published 2018-01-01

The role of the gut microbiome in sex differences in arterial pressure

by Anna L. Beale, David M. Kaye, Francine Z. Marques
Published 2019-04-01

Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fraction

by David M. Kaye, Melissa Byrne, Justin Mariani, Shane Nanayakkara, Daniel Burkhoff
Published 2020-12-01

Age-Related Differential Structural and Transcriptomic Responses in the Hypertensive Heart

by Francine Z. Marques, Francine Z. Marques, Po-Yin Chu, Mark Ziemann, Antony Kaspi, Helen Kiriazis, Xiao-Jun Du, Xiao-Jun Du, Assam El-Osta, Assam El-Osta, Assam El-Osta, David M. Kaye, David M. Kaye, David M. Kaye
Published 2018-07-01

Subclinical Left Ventricular Dysfunction is Influenced by Genotype Severity in Patients with Cystic Fibrosis

by Michael Pallin, Dominic Keating, David M Kaye, Tom Kotsimbos, John W Wilson
Published 2018-08-01

Insulin-mediated activation of the L-arginine nitric oxide pathway in man, and its impairment in diabetes.

by Niwanthi W Rajapakse, Abigail L Chong, Wei-Zheng Zhang, David M Kaye
Published 2013-01-01

Effects of Dietary l-Arginine on Nitric Oxide Bioavailability in Obese Normotensive and Obese Hypertensive Subjects

by Beverly Giam, Sanjaya Kuruppu, Geoffrey A. Head, David M. Kaye, Niwanthi W. Rajapakse
Published 2016-06-01

Augmented Endothelial-Specific L-Arginine Transport Blunts the Contribution of the Sympathetic Nervous System to Obesity Induced Hypertension in Mice.

by Niwanthi W Rajapakse, Florian Karim, Roger G Evans, David M Kaye, Geoffrey A Head
Published 2015-01-01

Nerve growth factor stimulates cardiac regeneration via cardiomyocyte proliferation in experimental heart failure.

by Nicholas T Lam, Peter D Currie, Graham J Lieschke, Nadia A Rosenthal, David M Kaye
Published 2012-01-01

Understanding the influence of left ventricular assist device inflow cannula alignment and the risk of intraventricular thrombosis

by Michael Neidlin, Sam Liao, Zhiyong Li, Benjamin Simpson, David M. Kaye, Ulrich Steinseifer, Shaun Gregory
Published 2021-05-01

Effect of oxygen on cardiac differentiation in mouse iPS cells: role of hypoxia inducible factor-1 and Wnt/beta-catenin signaling.

by Tanya L Medley, Milena Furtado, Nicholas T Lam, Rejhan Idrizi, David Williams, Paul J Verma, Mauro Costa, David M Kaye
Published 2013-01-01

The effect of parity on exercise physiology in women with heart failure with preserved ejection fraction

by Anna L. Beale, Carmela Cosentino, Louise Segan, Justin A. Mariani, Donna Vizi, Shona Evans, Shane Nanayakkara, David M. Kaye
Published 2020-02-01

CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis.

by Po-Yin Chu, Ken Walder, Duncan Horlock, David Williams, Erin Nelson, Melissa Byrne, Karin Jandeleit-Dahm, Paul Zimmet, David M Kaye
Published 2015-01-01

Abnormal mitochondrial L-arginine transport contributes to the pathogenesis of heart failure and rexoygenation injury.

by David Williams, Kylie M Venardos, Melissa Byrne, Mandar Joshi, Duncan Horlock, Nicholas T Lam, Paul Gregorevic, Sean L McGee, David M Kaye
Published 2014-01-01

Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart

by Duncan Horlock, David M. Kaye, Catherine E. Winbanks, Xiao-Ming Gao, Helen Kiriazis, Daniel G. Donner, Paul Gregorevic, Julie R. McMullen, Bianca C. Bernardo
Published 2021-03-01

Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trial

by Dakota Rhys-Jones, Rachel E. Climie, Paul A. Gill, Hamdi A. Jama, Geoffrey A. Head, Peter R. Gibson, David M. Kaye, Jane G. Muir, Francine Z. Marques
Published 2021-07-01

Characterising risk of in-hospital mortality following cardiac arrest using machine learning: A retrospective international registry study.

by Shane Nanayakkara, Sam Fogarty, Michael Tremeer, Kelvin Ross, Brent Richards, Christoph Bergmeir, Sheng Xu, Dion Stub, Karen Smith, Mark Tacey, Danny Liew, David Pilcher, David M Kaye
Published 2018-11-01

Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.

by Eliane Q Lin, Jennifer C Irvine, Anh H Cao, Amy E Alexander, Jane E Love, Ruchi Patel, Julie R McMullen, David M Kaye, Barbara K Kemp-Harper, Rebecca H Ritchie
Published 2012-01-01